Senior Researcher Spotlight: Kent Lai Develops Gene-Based Therapeutics for Congenital Disorders of Glycosylation Dakota Campbell Tue, 06/21/2022 - 09:48
Kent Lai, PhD, sitting in a chair in his lab

Kent Lai, PhD, is a professor in the Division of Medical Genetics (Pediatrics) at the University of Utah. He is also a member of the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC). His research focuses on the development of novel therapeutics for both common and rare diseases, including congenital disorders of glycosylation (CDG). Here, he shares his start in rare disease research, exciting discoveries, and future goals. 

FCDGC Announces 2021 Pilot Grant Award Recipients sheila.wolfer@… Mon, 04/19/2021 - 14:55
Heather Flanagan-Steet and Steven Sloan, 2021 Pilot Grant Winners
Heather Flanagan-Steet and Steven Sloan, 2021 FCDGC Pilot Grant Winners

The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC), in close partnership with CDG CARE, has awarded 2021 pilot grants to Heather Flanagan-Steet, PhD and Steven Sloan MD, PhD.

Researchers Identify New Congenital Disorder of Glycosylation, GALNT2-CDG Dakota Campbell Tue, 05/26/2020 - 12:00
Video abstract with graphic showing the process of O-glycosylation

Seven patients now have a name for their specific congenital disorder of glycosylation (CDG)—a new type called GALNT2-CDG. Researchers from Frontiers in Congenital Disorders of Glycosylation (FCDGC) describe the new disorder, caused by mutations in the GALNT2 gene, in the journal Brain.